A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A
Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- N/A
A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
- Status
- COMPLETED
- Phase
- N/A
CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Expanded Access for Anti-IL8
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access for Apixaban
- Status
- AVAILABLE
- Phase
- N/A